Publications

Regula Neuenschwander, Adrian Ciurea, et al.: Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort Arthritis Research & Therapy, October 2020

Adrian Ciurea, Axel Finckh, et al.: Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort [Annals in Rheumatic Diseases, September 2020](https://ard.bmj.com/content/annrheumdis/early/2020/09/22/annrheumdis-2020-218705.full.pdf

Adrian Ciurea, Michael Nissen et al.: Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration RMD Open, august 2020

Delphine S Courvoisier, Axel Finckh, et al.: The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries Rheumatology, August 2020

Raphael Micheroli, Adrian Ciurea et al.: Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort. Annals in Rheumatic Diseases, June 2020

Matthias Jarlborg, Michael Nissen et al.: Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Research and Therapy, May 2020

Axel Finckh, Pascal Zufferey et al.: Comparative Effectiveness of Antitumour Necrosis Factor Agents, Biologics With an Alternative Mode of Action and Tofacitinib in an Observational Cohort of Patients With Rheumatoid Arthritis in Switzerland. RMD Open, May 2020

Matthew Thomas, Burkhard Moeller et al.: Tumour Necrosis Factor Inhibitor monotherapy versus combination therapy for the treatment of psoriatic arthritis: combined analysis of European biologics databases. The Journal of Rheumatology April 2020

Monika Hebeisen, Adrian Ciurea et al.: Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort. Plos One, March 2020

Brigitte Michelsen, Adrian Ciurea et al.: Impact of discordance between patient’s and evaluator’s global assessment on treatment outcomes in 14 868 patients with spondyloarthritis. Rheumatology, January 2020

Yvette Meissner, Frauke Foerger et al.: European Network of Pregnancy Registers in Rheumatology (EuNeP)—an overview of procedures and data collection. Arthritis Research & Therapy, November 2019

CH Brahe, JM Nissen et al.: Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA. Rheumatology (Oxford), 2019 Oct 30, Epub ahead of print

Burkhard Möller, Michael Andor et al.: Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years. Rheumatology (Oxford). 2019 Oct 19. pii: kez460. doi: 10.1093/rheumatology/kez460

Lykke Midtbøll Ørnbjerg, Adrian Ciurea et al.: Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration. ARD Journals, Oktober 2019

Pascal Zufferey, Delphine S.Courvoisier et al.: Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real life. Joint Bone Spine, September 2019

Janick Rohrbach, Tobias Reinhard et al.: Bone erosion scoring for rheumatoid arthritis with deep convolutional neural networks. ScienceDirect, August 2019

Anne Boel, Adrian Ciurea et al.: Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts. BMJ Journals, July 2019

Kim Lauper, Denis Mongin, Deshire Alpizar-Rodriguez et al.: Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution. Rheumatology, June 2019

Monika Hebeisen, Adrian Ciurea et al.: Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis. PLOS|ONE, May 2019

Godehard A. Scholz, Alexander B. Leichtle, Burkhard Möller et al.: The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis. British Journal of Haematology, April 2019